KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Biogen (BIIB) Return on Sales (2016 - 2025)

Biogen has reported Return on Sales over the past 17 years, most recently at 0.02% for Q4 2025.

  • Quarterly results put Return on Sales at 0.02% for Q4 2025, down 13.0% from a year ago — trailing twelve months through Dec 2025 was 0.13% (down 4.0% YoY), and the annual figure for FY2025 was 0.13%, down 4.0%.
  • Return on Sales for Q4 2025 was 0.02% at Biogen, down from 0.18% in the prior quarter.
  • Over the last five years, Return on Sales for BIIB hit a ceiling of 0.45% in Q3 2022 and a floor of 0.03% in Q3 2023.
  • Median Return on Sales over the past 5 years was 0.16% (2023), compared with a mean of 0.17%.
  • Biggest five-year swings in Return on Sales: surged 34bps in 2022 and later plummeted -48bps in 2023.
  • Biogen's Return on Sales stood at 0.01% in 2021, then skyrocketed by 1646bps to 0.22% in 2022, then plummeted by -52bps to 0.1% in 2023, then increased by 4bps to 0.11% in 2024, then plummeted by -120bps to 0.02% in 2025.
  • The last three reported values for Return on Sales were 0.02% (Q4 2025), 0.18% (Q3 2025), and 0.24% (Q2 2025) per Business Quant data.